首页 > 最新文献

Clinical ophthalmology (Auckland, N.Z.)最新文献

英文 中文
Brolucizumab versus Aflibercept in Patients with Diabetic Macular Edema: A Meta-Analysis of Randomized Controlled Trials. 糖尿病黄斑水肿患者中的布卢单抗与阿非利百普:随机对照试验的 Meta 分析。
Pub Date : 2024-12-10 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S487055
Leonardo B Justino, Gustavo B Justino, Fabrissio P Graffunder, William W Binotti, Ali Khodor, Jonathan T Caranfa

Purpose: To assess efficacy and safety of brolucizumab versus aflibercept in patients with diabetic macular edema (DME).

Patients and methods: We performed a systematic review and meta-analysis with trial sequential analysis (TSA). We searched Embase, Cochrane Central Register of Controlled Trials and PubMed databases from inception to February 16, 2024 for randomized controlled trials (RCTs) comparing brolucizumab with aflibercept in patients with DME and reporting any of the visual, anatomical and safety outcomes of interest. We conducted a TSA of safety outcomes to assess the risk of statistical errors.

Results: 1253 patients (1253 eyes) from 3 RCTs were included, of whom 57% received brolucizumab and 43% received aflibercept. Mean follow-up ranged from 52 to 100 weeks. Brolucizumab was non-inferior to aflibercept when comparing the mean change of best-corrected visual acuity from baseline (least squares mean difference [LSMD] 0.29; 95% confidence interval [CI] -1.37 to 1.95; p = 0.73). Change in central subfield thickness was significantly greater in the brolucizumab group compared with aflibercept (LSMD -24.5 μm; 95% CI -48.2 to -0.7 μm; p < 0.05). Incidence of adverse events of special interest (AESIs) (risk ratio [RR] 1.7; p = 0.08) and incidence of ≥1 ocular adverse events (AEs) (RR 0.95; p = 0.45) were not significantly different between groups.

Conclusion: Brolucizumab was non-inferior in functional outcomes and was superior to aflibercept in anatomical parameters. Ocular AEs and AESIs were numerically low and not statistically significant. Our findings underscore the importance of new RCTs powered to assess safety outcomes in order to suggest brolucizumab as an alternative to the treatment of DME.

目的:评估糖尿病黄斑水肿(DME)患者使用brolucizumab与aflibercept的疗效和安全性:我们通过试验序列分析(TSA)进行了系统回顾和荟萃分析。我们检索了 Embase、Cochrane Central Register of Controlled Trials 和 PubMed 数据库中从开始到 2024 年 2 月 16 日的随机对照试验 (RCT),这些试验对 DME 患者的视觉、解剖和安全性结果进行了报告。我们对安全性结果进行了TSA,以评估统计错误的风险:结果:纳入了来自3项RCT的1253名患者(1253只眼睛),其中57%接受了brolucizumab治疗,43%接受了aflibercept治疗。平均随访时间从52周到100周不等。在比较最佳矫正视力与基线相比的平均变化时,布卢单抗的疗效不劣于阿夫利拜特(最小二乘法平均差 [LSMD] 0.29;95% 置信区间 [CI] -1.37 至 1.95;P = 0.73)。与阿夫利百普相比,brolucizumab组的中央子场厚度变化明显更大(LSMD -24.5 μm;95% CI -48.2 to -0.7 μm;p < 0.05)。特别关注的不良事件(AESIs)发生率(风险比[RR] 1.7;p = 0.08)和≥1次眼部不良事件(AEs)发生率(RR 0.95;p = 0.45)在组间无显著差异:结论:布鲁珠单抗在功能结果方面不劣于阿夫利拜因,而在解剖参数方面优于阿夫利拜因。眼部AEs和AESIs数量较少,且无统计学意义。我们的研究结果表明,为了建议将布卢单抗作为治疗二极体视网膜病变的替代药物,必须开展新的研究试验,以评估安全性结果。
{"title":"Brolucizumab versus Aflibercept in Patients with Diabetic Macular Edema: A Meta-Analysis of Randomized Controlled Trials.","authors":"Leonardo B Justino, Gustavo B Justino, Fabrissio P Graffunder, William W Binotti, Ali Khodor, Jonathan T Caranfa","doi":"10.2147/OPTH.S487055","DOIUrl":"10.2147/OPTH.S487055","url":null,"abstract":"<p><strong>Purpose: </strong>To assess efficacy and safety of brolucizumab versus aflibercept in patients with diabetic macular edema (DME).</p><p><strong>Patients and methods: </strong>We performed a systematic review and meta-analysis with trial sequential analysis (TSA). We searched Embase, Cochrane Central Register of Controlled Trials and PubMed databases from inception to February 16, 2024 for randomized controlled trials (RCTs) comparing brolucizumab with aflibercept in patients with DME and reporting any of the visual, anatomical and safety outcomes of interest. We conducted a TSA of safety outcomes to assess the risk of statistical errors.</p><p><strong>Results: </strong>1253 patients (1253 eyes) from 3 RCTs were included, of whom 57% received brolucizumab and 43% received aflibercept. Mean follow-up ranged from 52 to 100 weeks. Brolucizumab was non-inferior to aflibercept when comparing the mean change of best-corrected visual acuity from baseline (least squares mean difference [LSMD] 0.29; 95% confidence interval [CI] -1.37 to 1.95; p = 0.73). Change in central subfield thickness was significantly greater in the brolucizumab group compared with aflibercept (LSMD -24.5 μm; 95% CI -48.2 to -0.7 μm; p < 0.05). Incidence of adverse events of special interest (AESIs) (risk ratio [RR] 1.7; p = 0.08) and incidence of ≥1 ocular adverse events (AEs) (RR 0.95; p = 0.45) were not significantly different between groups.</p><p><strong>Conclusion: </strong>Brolucizumab was non-inferior in functional outcomes and was superior to aflibercept in anatomical parameters. Ocular AEs and AESIs were numerically low and not statistically significant. Our findings underscore the importance of new RCTs powered to assess safety outcomes in order to suggest brolucizumab as an alternative to the treatment of DME.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3679-3690"},"PeriodicalIF":0.0,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11645907/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142831238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the Affordable, Portable International Visionkeys System for Visual Acuity and Stereopsis. 验证经济实惠的便携式国际视觉系统(Visionkeys)的视力和立体感。
Pub Date : 2024-12-10 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S494457
Lily A Karlberg, Taylor R Sweeney, Robert W Arnold

Background: A new, portable computerized distance vision testing (screen plus remote) system called VisionKeys has been developed by the missions equipment developer EyeMobil so we validated it compared to conventional research testing devices.

Methods: Using a standardized protocol of surround HOTV optotype presentation, the VisionKeys was compared to M&S for patched monocular distance visual acuity. A different VisionKeys function with anaglyph spectacle distance stereopsis was compared to near stereo on Titmus circles with Polaroid goggles and PDI Check on an autostereoscopic screen. Raw scores were converted to logarithm and compared with non-parametric and Bland Altman tests.

Results: We recruited 145 ethnically diverse patients with range of acuity -0.4 to 2.6 (NLP) logMAR from a pediatric eye and adult strabismus practice showing median logMAR acuity of 0.0 with VisionKeys significantly finer resolution than 0.1 for M&S (Mann-Whitney z=2.6, p=0.01, n=290). VisionKeys acuity correlated very well with M&S and children under age 7 scored coarser than teens and young adults. Median distance log arc seconds stereo on VisionKeys (2.00) differed from near Titmus circles (1.78) and PDI Check (1.89, Kruskal-Wallis X2(2)=9.8, p=0.007) however they all correlated well by Bland Altman.

Conclusion: The new, portable VisionKeys system gives valid distance visual acuity with slightly finer estimate compared to M&S and the distance stereo compared well with near Titmus and PDI Check. As such, it should be valuable for testing children and adults in remote locations.

背景:任务设备开发商 EyeMobil 开发了一种名为 VisionKeys 的新型便携式计算机化远距离视力测试(屏幕加遥控器)系统,因此我们将其与传统的研究测试设备进行了比较验证:方法: 使用环绕 HOTV 光型演示的标准化协议,将 VisionKeys 与 M&S 的单眼距离视敏度进行比较。将 VisionKeys 的不同功能与戴着宝丽来护目镜的 Titmus 圆圈上的近立体和自动立体屏幕上的 PDI 检查进行了比较。原始分数被转换成对数,并通过非参数检验和布兰德-阿尔特曼检验进行比较:我们招募了145名来自不同种族的患者,他们的视力范围为-0.4至2.6(NLP)logMAR,来自一家小儿眼科和成人斜视诊所,显示中位logMAR视力为0.0,VisionKeys的分辨率明显比M&S的0.1更精细(Mann-Whitney z=2.6,p=0.01,n=290)。VisionKeys 的敏锐度与 M&S 的敏锐度有很好的相关性,7 岁以下儿童的评分比青少年和年轻成人要粗。VisionKeys 的中位距离对数弧秒立体视(2.00)与近距离 Titmus 圆(1.78)和 PDI 检查(1.89,Kruskal-Wallis X2(2)=9.8,p=0.007)不同,但它们在 Bland Altman 中的相关性都很好:结论:新的便携式 VisionKeys 系统能提供有效的远距离视力,与 M&S 系统相比,其估计值略微精细,而且远距离立体视力与近距离 Titmus 和 PDI 检查相比也很好。因此,该系统对偏远地区的儿童和成人测试很有价值。
{"title":"Validation of the Affordable, Portable International Visionkeys System for Visual Acuity and Stereopsis.","authors":"Lily A Karlberg, Taylor R Sweeney, Robert W Arnold","doi":"10.2147/OPTH.S494457","DOIUrl":"10.2147/OPTH.S494457","url":null,"abstract":"<p><strong>Background: </strong>A new, portable computerized distance vision testing (screen plus remote) system called VisionKeys has been developed by the missions equipment developer EyeMobil so we validated it compared to conventional research testing devices.</p><p><strong>Methods: </strong>Using a standardized protocol of surround HOTV optotype presentation, the VisionKeys was compared to M&S for patched monocular distance visual acuity. A different VisionKeys function with anaglyph spectacle distance stereopsis was compared to near stereo on Titmus circles with Polaroid goggles and PDI Check on an autostereoscopic screen. Raw scores were converted to logarithm and compared with non-parametric and Bland Altman tests.</p><p><strong>Results: </strong>We recruited 145 ethnically diverse patients with range of acuity -0.4 to 2.6 (NLP) logMAR from a pediatric eye and adult strabismus practice showing median logMAR acuity of 0.0 with VisionKeys significantly finer resolution than 0.1 for M&S (Mann-Whitney z=2.6, p=0.01, n=290). VisionKeys acuity correlated very well with M&S and children under age 7 scored coarser than teens and young adults. Median distance log arc seconds stereo on VisionKeys (2.00) differed from near Titmus circles (1.78) and PDI Check (1.89, Kruskal-Wallis X2(2)=9.8, p=0.007) however they all correlated well by Bland Altman.</p><p><strong>Conclusion: </strong>The new, portable VisionKeys system gives valid distance visual acuity with slightly finer estimate compared to M&S and the distance stereo compared well with near Titmus and PDI Check. As such, it should be valuable for testing children and adults in remote locations.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3667-3677"},"PeriodicalIF":0.0,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11645953/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142831246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolution of Workload Associated with Anti-VEGF Treatments for AMD, DME, RVO and mCNV in Hospital District of Southwest Finland. 芬兰西南部地区医院抗血管内皮生长因子治疗老年性黄斑变性、老年性黑斑变性、老年性视网膜病变和间变性视网膜病变的工作量变化。
Pub Date : 2024-12-08 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S479816
Hanna Heloterä, Anna-Mari Viita, Juha Laine

Background: The prevalence of vision-threatening diseases, such as age-related macular degeneration (AMD) and diabetic macular edema (DME), is likely to increase in developed countries owing to an aging population, rising life expectancy, and unfavorable lifestyle changes. Increases in the burden of vision-threatening diseases pose a challenge to the healthcare system. After the emergence of intravitreal anti-VEGF inhibitors, treatment options for neovascular AMD (nAMD), DME, retinal vein occlusion (RVO) and myopic choroidal neovascularization (myopic CNV) have increased. As this change in treatment practices has occurred over the last two decades, it is important to demonstrate changes in patient numbers and administered treatments to provide solutions for handling the workload and productivity in ophthalmology departments. In addition, the registry data landscape has evolved in Finland in recent years. Thus, understanding the possibilities and limitations of ophthalmology registries and patient information systems is required.

Methods: This study involved the secondary use of retrospectively registered data from the data warehouse of the Hospital District of Southwest Finland. Our goal was to explore how the workload of ophthalmology departments caused by intravitreal injections has evolved from 2015 to 2022.

Results: The ophthalmology department workload increased significantly during our observation period as the total number of patients receiving intravitreal treatments for nAMD, DME, RVO, and myopic CNV increased 199.6% from 2015 to 2021. In addition, the total number of administered anti-VEGF injections increased during our observation period, but the increase rate began to subside (2019-2020: increase 23.7%, 2020-2021: increase 10.3%, 2021-2022: increase 6.7%).

Conclusion: Supporting the utilization of registry data is essential in evidence-based discussions evolving workload in healthcare. However, it is important to understand the limitations and the quality of the registries. Our study contributes to better understanding the Finnish registry perspective, and it demonstrates the increase in workload in ophthalmology departments caused by intravitreal injections.

背景:由于人口老龄化、预期寿命延长以及不利的生活方式改变,威胁视力的疾病,如老年性黄斑变性(AMD)和糖尿病性黄斑水肿(DME),在发达国家的发病率可能会增加。危及视力疾病负担的增加给医疗保健系统带来了挑战。在玻璃体内抗血管内皮生长因子抑制剂出现后,治疗新生血管性黄斑变性(nAMD)、视网膜黄斑变性(DME)、视网膜静脉闭塞(RVO)和近视性脉络膜新生血管(近视性 CNV)的选择增加了。由于治疗方法在过去二十年中发生了变化,因此必须展示患者人数和治疗方法的变化,以便为处理眼科部门的工作量和生产率提供解决方案。此外,近年来芬兰的登记数据情况也发生了变化。因此,需要了解眼科登记和患者信息系统的可能性和局限性:本研究对芬兰西南部医院区数据仓库中的回顾性登记数据进行了二次利用。我们的目标是探索从2015年到2022年,眼科部门因玻璃体内注射而产生的工作量是如何变化的:结果:在我们的观察期内,眼科部门的工作量显著增加,因为从 2015 年到 2021 年,接受玻璃体内治疗的 nAMD、DME、RVO 和近视 CNV 患者总数增加了 199.6%。此外,在我们的观察期内,抗血管内皮生长因子注射的总次数也有所增加,但增幅开始减弱(2019-2020 年:增加 23.7%;2020-2021 年:增加 10.3%;2021-2022 年:增加 6.7%):支持利用登记册数据对于循证讨论医疗保健中不断变化的工作量至关重要。然而,了解登记册的局限性和质量也很重要。我们的研究有助于更好地理解芬兰登记处的观点,并证明了玻璃体内注射导致眼科工作量的增加。
{"title":"Evolution of Workload Associated with Anti-VEGF Treatments for AMD, DME, RVO and mCNV in Hospital District of Southwest Finland.","authors":"Hanna Heloterä, Anna-Mari Viita, Juha Laine","doi":"10.2147/OPTH.S479816","DOIUrl":"10.2147/OPTH.S479816","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of vision-threatening diseases, such as age-related macular degeneration (AMD) and diabetic macular edema (DME), is likely to increase in developed countries owing to an aging population, rising life expectancy, and unfavorable lifestyle changes. Increases in the burden of vision-threatening diseases pose a challenge to the healthcare system. After the emergence of intravitreal anti-VEGF inhibitors, treatment options for neovascular AMD (nAMD), DME, retinal vein occlusion (RVO) and myopic choroidal neovascularization (myopic CNV) have increased. As this change in treatment practices has occurred over the last two decades, it is important to demonstrate changes in patient numbers and administered treatments to provide solutions for handling the workload and productivity in ophthalmology departments. In addition, the registry data landscape has evolved in Finland in recent years. Thus, understanding the possibilities and limitations of ophthalmology registries and patient information systems is required.</p><p><strong>Methods: </strong>This study involved the secondary use of retrospectively registered data from the data warehouse of the Hospital District of Southwest Finland. Our goal was to explore how the workload of ophthalmology departments caused by intravitreal injections has evolved from 2015 to 2022.</p><p><strong>Results: </strong>The ophthalmology department workload increased significantly during our observation period as the total number of patients receiving intravitreal treatments for nAMD, DME, RVO, and myopic CNV increased 199.6% from 2015 to 2021. In addition, the total number of administered anti-VEGF injections increased during our observation period, but the increase rate began to subside (2019-2020: increase 23.7%, 2020-2021: increase 10.3%, 2021-2022: increase 6.7%).</p><p><strong>Conclusion: </strong>Supporting the utilization of registry data is essential in evidence-based discussions evolving workload in healthcare. However, it is important to understand the limitations and the quality of the registries. Our study contributes to better understanding the Finnish registry perspective, and it demonstrates the increase in workload in ophthalmology departments caused by intravitreal injections.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3645-3655"},"PeriodicalIF":0.0,"publicationDate":"2024-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11640760/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142831241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined Phacoemulsification and 360-Degree Suture Trabeculotomy Ab Externo in Primary Chronic Angle Closure Glaucoma: A Modified Technique. 超声乳化联合体外360度缝合小梁切开术治疗原发性闭角型青光眼的改良技术。
Pub Date : 2024-12-07 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S480485
Abdelhamid Shaker Elhofi, Hany Ahmed Helaly, Rania Eldakhs

Purpose: To assess the outcome of combined phacoemulsification and 360-degree suture trabeculotomy ab externo in chronic angle closure glaucoma using a modified technique.

Methods: This is a retrospective clinical study that included 60 eyes of 60 patients who had undergone combined phacoemulsification and 360-degree suture trabeculotomy ab externo for the treatment of primary chronic angle closure glaucoma. The patients were divided into two groups. The first group (ab externo group) and the second group (modified ab externo group). Data were collected from the records and the final follow-up visit including age, sex, intraocular pressure (IOP), number of antiglaucoma medications, presence of complications, corrected distant visual acuity, and need for another intervention. All the included patients completed at least 12 months follow-up.

Results: The ab externo group included 30 patients and the modified ab externo group included 30 patients. The postoperative IOP was reduced in both groups significantly from the preoperative levels. The percent of reduction was around 60% for both groups (59.5% for the ab externo group and 59.3% for the modified ab externo group). There was statistically significant reduction in the mean amount of required topical medications after the intervention for both groups (p = 0.001). Most of the complications were not serious. Around 90% of the cases in both groups had mild degree of grade 1 hyphema.

Conclusion: Both ab externo 360 degree suture trabeculotomy and its modified technique with ab interno pulling of the suture when combined with phacoemulsification are safe and provide adequate decrease in the intraocular pressure. Modified technique of ab interno pulling of the prolene suture might be more gentle procedure with less severe hyphema and lower chance of rupture of trabeculo-Descemet's membrane.

目的:评价改良超声乳化联合体外360度缝合小梁切开术治疗慢性闭角型青光眼的疗效。方法:回顾性临床研究60例60眼,行超声乳化联合体外360度缝合小梁切开术治疗原发性慢性闭角型青光眼。患者被分为两组。第一组(ab externo组)和第二组(修改后的ab externo组)。从记录和最后的随访中收集数据,包括年龄、性别、眼压(IOP)、抗青光眼药物的数量、并发症的存在、矫正的远视力以及是否需要另一次干预。所有纳入的患者均完成了至少12个月的随访。结果:体外移植组30例,改良体外移植组30例。两组术后IOP均较术前显著降低。两组的减少率都在60%左右(体外注射组为59.5%,改良体外注射组为59.3%)。干预后两组患者所需外用药物的平均用量均有统计学意义的降低(p = 0.001)。大多数并发症并不严重。两组病例中约90%为轻度1级前房积血。结论:体外360度缝合小梁切开术及其改良术联合超声乳化术是安全的,并能充分降低眼压。改良的腹肌间牵引法是一种较温和的手术方法,可减少严重的前房积血,减少小梁-后小梁膜破裂的机会。
{"title":"Combined Phacoemulsification and 360-Degree Suture Trabeculotomy Ab Externo in Primary Chronic Angle Closure Glaucoma: A Modified Technique.","authors":"Abdelhamid Shaker Elhofi, Hany Ahmed Helaly, Rania Eldakhs","doi":"10.2147/OPTH.S480485","DOIUrl":"10.2147/OPTH.S480485","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the outcome of combined phacoemulsification and 360-degree suture trabeculotomy ab externo in chronic angle closure glaucoma using a modified technique.</p><p><strong>Methods: </strong>This is a retrospective clinical study that included 60 eyes of 60 patients who had undergone combined phacoemulsification and 360-degree suture trabeculotomy ab externo for the treatment of primary chronic angle closure glaucoma. The patients were divided into two groups. The first group (ab externo group) and the second group (modified ab externo group). Data were collected from the records and the final follow-up visit including age, sex, intraocular pressure (IOP), number of antiglaucoma medications, presence of complications, corrected distant visual acuity, and need for another intervention. All the included patients completed at least 12 months follow-up.</p><p><strong>Results: </strong>The ab externo group included 30 patients and the modified ab externo group included 30 patients. The postoperative IOP was reduced in both groups significantly from the preoperative levels. The percent of reduction was around 60% for both groups (59.5% for the ab externo group and 59.3% for the modified ab externo group). There was statistically significant reduction in the mean amount of required topical medications after the intervention for both groups (p = 0.001). Most of the complications were not serious. Around 90% of the cases in both groups had mild degree of grade 1 hyphema.</p><p><strong>Conclusion: </strong>Both ab externo 360 degree suture trabeculotomy and its modified technique with ab interno pulling of the suture when combined with phacoemulsification are safe and provide adequate decrease in the intraocular pressure. Modified technique of ab interno pulling of the prolene suture might be more gentle procedure with less severe hyphema and lower chance of rupture of trabeculo-Descemet's membrane.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3657-3666"},"PeriodicalIF":0.0,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11633301/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142815321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation, Evaluation and Validation of the Adult Strabismus -20 (AS-20) Questionnaire in Swedish. 瑞典语成人斜视-20 (AS-20)问卷的翻译、评估与验证。
Pub Date : 2024-12-07 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S477032
Lena Havstam Johansson, Anna Levinsson, Sara M Flodin

Purpose: To translate and validate the Adult Strabismus 20 (AS-20) questionnaire, a health-related quality of life questionnaire specifically devised for patients with strabismus.

Methods: The AS-20 was translated in accordance with the principles of good practice for the translation and cultural adaptation process for patient-related outcomes (PRO) according to the methodology recommended by the International Society for Pharmacoeconomics and Outcome Research (ISPOR). The translation, evaluation, and validation were performed in several steps. The study used both qualitative and quantitative methods and engaged 31 final-year orthoptic students in workshops, as well as 19 experts (experienced clinical orthoptists), 17 laymen (members of the public), and 17 patients from national eye clinics. The final translated questionnaire was tested for reliability and validity in 68 adults with strabismus by internal consistency using Cronbach´s alpha and content and construct validity using the Rasch analysis.

Results: The Swedish AS-20 showed a high level of internal consistency. Cronbach´s alpha was 0.95 for the psychosocial subscale and 0.92 for the functional subscale. However, the Rasch analysis indicated that both items and responses should be condensed to achieve content and construct validity.

Conclusion: The thorough translation and evaluation process resulted in a validated AS-20 questionnaire for use in the Swedish language, and shows reliability as an instrument to measure health-related quality of life (HRQoL) in adults with strabismus in a clinical setting.

目的:翻译并验证成人斜视20 (AS-20)问卷,这是一份专门为斜视患者设计的与健康相关的生活质量问卷。方法:按照患者相关结果(PRO)翻译和文化适应过程的良好实践原则,按照国际药物经济学与结果研究学会(ISPOR)推荐的方法对AS-20进行翻译。翻译、评估和验证分几个步骤进行。本研究采用定性和定量相结合的方法,研究对象包括31名参加研修班的大四学生、19名专家(经验丰富的临床眼科医生)、17名外行(公众)和17名来自国家眼科诊所的患者。采用Cronbach’s alpha和content对68名斜视成人的最终翻译问卷进行了信度和效度的内部一致性检验,并采用Rasch分析进行了结构效度检验。结果:瑞典AS-20量表具有较高的内部一致性。心理社会分量表的Cronbach’s alpha为0.95,功能分量表的Cronbach’s alpha为0.92。然而,Rasch分析表明,项目和回答都应该精简,以达到内容效度和结构效度。结论:经过全面的翻译和评估,得出了一份经过验证的瑞典语as -20问卷,并显示了作为临床环境中衡量成人斜视患者健康相关生活质量(HRQoL)工具的可靠性。
{"title":"Translation, Evaluation and Validation of the Adult Strabismus -20 (AS-20) Questionnaire in Swedish.","authors":"Lena Havstam Johansson, Anna Levinsson, Sara M Flodin","doi":"10.2147/OPTH.S477032","DOIUrl":"10.2147/OPTH.S477032","url":null,"abstract":"<p><strong>Purpose: </strong>To translate and validate the Adult Strabismus 20 (AS-20) questionnaire, a health-related quality of life questionnaire specifically devised for patients with strabismus.</p><p><strong>Methods: </strong>The AS-20 was translated in accordance with the principles of good practice for the translation and cultural adaptation process for patient-related outcomes (PRO) according to the methodology recommended by the International Society for Pharmacoeconomics and Outcome Research (ISPOR). The translation, evaluation, and validation were performed in several steps. The study used both qualitative and quantitative methods and engaged 31 final-year orthoptic students in workshops, as well as 19 experts (experienced clinical orthoptists), 17 laymen (members of the public), and 17 patients from national eye clinics. The final translated questionnaire was tested for reliability and validity in 68 adults with strabismus by internal consistency using Cronbach´s alpha and content and construct validity using the Rasch analysis.</p><p><strong>Results: </strong>The Swedish AS-20 showed a high level of internal consistency. Cronbach´s alpha was 0.95 for the psychosocial subscale and 0.92 for the functional subscale. However, the Rasch analysis indicated that both items and responses should be condensed to achieve content and construct validity.</p><p><strong>Conclusion: </strong>The thorough translation and evaluation process resulted in a validated AS-20 questionnaire for use in the Swedish language, and shows reliability as an instrument to measure health-related quality of life (HRQoL) in adults with strabismus in a clinical setting.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3615-3625"},"PeriodicalIF":0.0,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11633298/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142815324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics and Prognostic Factors of Patients with Intraocular Foreign Bodies from a Tertiary Eye Center in North China. 华北某三级眼科中心眼内异物的临床特点及预后因素分析。
Pub Date : 2024-12-07 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S492986
Xiaoli Xing, Fang Liu, Yan Qi, Jun Li, Bin Yu, Lei Wan

Background: This study aims to describe the epidemiology and clinical features of patients with intraocular foreign bodies (IOFBs) and analyze the prognostic factors influencing final vision.

Methods: We retrospectively reviewed medical records of patients with IOFBs admitted to Qingdao Eye Hospital of Shandong First Medical University between January 1, 2014, and December 31, 2021. Inclusion criteria involved complete clinical data details of patients diagnosed with intraocular foreign bodies in our hospital who were treated with concurrent surgery and based on IOFB position and characteristics, different surgical methods were employed. The minimum follow-up duration was 6 months. Exclusion criteria were foreign bodies retained in the orbit, organ failure, surgical contraindications, coagulation abnormalities, autoimmune diseases, history of ocular surgery, and ocular space-occupying lesions. Based on IOFB position and characteristics, different surgical methods were employed. Multivariate logistic regression analysis was performed to predict independent factors influencing final visual acuity after IOFBs.

Results: This study analyzed 159 patients (159 eyes) with IOFBs. Based on discharge and follow-up results, IOFB removal was performed through pars plana incision in 105 (67.9%) eyes, corneoscleral limbus incision in 24 (15.1%) eyes, and original wound in 27 (17.0%) eyes. Of these, 44 eyes underwent IOFB removal without vitrectomy, while 55 (34.6%) eyes were treated with silicone oil. Post-vitrectomy, three cases showed secondary macular membrane, five cases exhibited retinal detachment, and enucleation was necessary in three cases. The final best corrected visual acuity (BCVA, logMAR) was 1.06 ±0.88, significantly better than preoperative visual acuity of 1.65 ±0.87 (t = 8.21, p < 0.01). Multi-factor logistic regression analysis revealed that the length of corneal/scleral wound (OR=0.6 P < 0.05), maximum size of IOFB (OR=0.585 P < 0.05), initial presenting VA (OR=0.900 P < 0.05), and macular lesions(OR=0.400 P < 0.05) were risk factors for postoperative vision prognosis after intraocular foreign body surgery.

Conclusion: In a tertiary eye center in northern China, IOFBs predominantly affected the working-age group, particularly males. Factors such as wound length, IOFB size, initial presenting VA, and macular lesions might impact the final visual outcome.

背景:本研究旨在描述眼内异物(IOFBs)患者的流行病学和临床特征,并分析影响最终视力的预后因素。方法:回顾性分析2014年1月1日至2021年12月31日山东第一医科大学青岛眼科医院收治的IOFBs患者的病历。纳入标准包括我院诊断为眼内异物且同时行手术治疗的患者完整的临床资料细节,并根据IOFB的位置和特点,采用不同的手术方法。最小随访时间为6个月。排除标准为眼眶异物、器官衰竭、手术禁忌症、凝血异常、自身免疫性疾病、眼部手术史和眼部占位性病变。根据IOFB的位置和特点,采用不同的手术方法。采用多因素logistic回归分析预测影响IOFBs术后最终视力的独立因素。结果:本研究分析了159例(159眼)iofb患者。根据出院及随访结果,经平面部切口105例(67.9%),角膜巩膜缘切口24例(15.1%),原创处27例(17.0%)。其中,44只眼不切除玻璃体而摘除IOFB, 55只眼(34.6%)使用硅油。玻璃体切除术后,3例出现继发性黄斑膜,5例出现视网膜脱离,3例需要摘除视网膜核。最终最佳矫正视力(BCVA, logMAR)为1.06±0.88,明显优于术前的1.65±0.87 (t = 8.21, p < 0.01)。多因素logistic回归分析显示,角膜/巩膜创面长度(OR=0.6 P < 0.05)、IOFB最大尺寸(OR=0.585 P < 0.05)、首发VA (OR=0.900 P < 0.05)、黄斑病变(OR=0.400 P < 0.05)是影响眼内异物术后视力预后的危险因素。结论:在中国北方某三级眼科中心,IOFBs主要影响工作年龄人群,尤其是男性。诸如伤口长度、IOFB大小、初始表现VA和黄斑病变等因素可能影响最终的视力结果。
{"title":"Clinical Characteristics and Prognostic Factors of Patients with Intraocular Foreign Bodies from a Tertiary Eye Center in North China.","authors":"Xiaoli Xing, Fang Liu, Yan Qi, Jun Li, Bin Yu, Lei Wan","doi":"10.2147/OPTH.S492986","DOIUrl":"10.2147/OPTH.S492986","url":null,"abstract":"<p><strong>Background: </strong>This study aims to describe the epidemiology and clinical features of patients with intraocular foreign bodies (IOFBs) and analyze the prognostic factors influencing final vision.</p><p><strong>Methods: </strong>We retrospectively reviewed medical records of patients with IOFBs admitted to Qingdao Eye Hospital of Shandong First Medical University between January 1, 2014, and December 31, 2021. Inclusion criteria involved complete clinical data details of patients diagnosed with intraocular foreign bodies in our hospital who were treated with concurrent surgery and based on IOFB position and characteristics, different surgical methods were employed. The minimum follow-up duration was 6 months. Exclusion criteria were foreign bodies retained in the orbit, organ failure, surgical contraindications, coagulation abnormalities, autoimmune diseases, history of ocular surgery, and ocular space-occupying lesions. Based on IOFB position and characteristics, different surgical methods were employed. Multivariate logistic regression analysis was performed to predict independent factors influencing final visual acuity after IOFBs.</p><p><strong>Results: </strong>This study analyzed 159 patients (159 eyes) with IOFBs. Based on discharge and follow-up results, IOFB removal was performed through pars plana incision in 105 (67.9%) eyes, corneoscleral limbus incision in 24 (15.1%) eyes, and original wound in 27 (17.0%) eyes. Of these, 44 eyes underwent IOFB removal without vitrectomy, while 55 (34.6%) eyes were treated with silicone oil. Post-vitrectomy, three cases showed secondary macular membrane, five cases exhibited retinal detachment, and enucleation was necessary in three cases. The final best corrected visual acuity (BCVA, logMAR) was 1.06 ±0.88, significantly better than preoperative visual acuity of 1.65 ±0.87 (t = 8.21, p < 0.01). Multi-factor logistic regression analysis revealed that the length of corneal/scleral wound (OR=0.6 P < 0.05), maximum size of IOFB (OR=0.585 P < 0.05), initial presenting VA (OR=0.900 P < 0.05), and macular lesions(OR=0.400 P < 0.05) were risk factors for postoperative vision prognosis after intraocular foreign body surgery.</p><p><strong>Conclusion: </strong>In a tertiary eye center in northern China, IOFBs predominantly affected the working-age group, particularly males. Factors such as wound length, IOFB size, initial presenting VA, and macular lesions might impact the final visual outcome.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3635-3643"},"PeriodicalIF":0.0,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11633304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142815318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bio-Interventional Cyclodialysis and Allograft Scleral Reinforcement for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients: One-Year Clinical Outcomes. 生物介入睫状体透析和同种异体巩膜强化治疗开角型青光眼患者的巩膜流出增强:一年临床结果。
Pub Date : 2024-12-06 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S496631
Tsontcho Ianchulev, Robert N Weinreb, Ernesto A Calvo, James Lewis, Gautam Kamthan, Arsham Sheybani, Douglas J Rhee, Iqbal K Ahmed

Background: To evaluate the one-year safety and effectiveness of bio-interventional cyclodialysis and scleral reinforcement in open-angle glaucoma (OAG) patients undergoing cataract surgery.

Methods: An ab-interno approach was used to create a sectoral cyclodialysis in OAG patients who were prospectively followed in a consecutive case series. Subsequent visco-cycloplasty with scleral reinforcement using homologous minimally modified allograft scaffold was completed to maintain patency of the cyclodialysis reservoir and increase uveoscleral outflow. Outcomes were mean medicated IOP and mean number of IOP-lowering medications. Safety outcomes were adverse events (AEs) and best-corrected visual acuity (BCVA) changes.

Results: Successful cyclodialysis and allograft bio-scaffold reinforcement was achieved in 117 eyes. There was minimal intraoperatie bleeding and few post-operative adverse events. At baseline, mean BCVA was 0.48 (95% CI: 0.42‒0.54; 20/40 Snellen) and mean ± SD medicated IOP was 20.2 ± 6.0 mmHg on 1.4 ± 1.3 IOP-lowering medications. At 12 months, there was a 27.1% reduction from baseline mean medicated IOP. In eyes with medicated baseline IOP > 21 mmHg (n = 45), there was a 39.7% paired IOP reduction at 12 months with a concurrent reduction in the mean number of IOP lowering medications to 0.8 ± 0.9 which were statistically significant (p < 0.01). For all eyes, 81.9% achieved a medicated IOP ≤ 18 mmHg with no increase in medications at 12 months. To achieve target IOP control, secondary glaucoma surgery was performed in 3.2% of the cases.

Conclusion: IOP lowering through uveoscleral outflow enhancement can be achieved by means of a bio-interventional cyclodialysis procedure with allograft scleral reinforcement.

背景:评价开角型青光眼(OAG)白内障手术患者生物介入睫状体透析和巩膜加固治疗一年的安全性和有效性。方法:采用ab-interno方法对连续病例系列前瞻性随访的OAG患者进行部门性循环透析。随后使用同源最小修饰同种异体支架进行巩膜加固的黏液环成形术,以维持环透析库的通畅并增加巩膜流出。结果是平均药物IOP和平均降低IOP药物的数量。安全性结果为不良事件(ae)和最佳矫正视力(BCVA)变化。结果:117眼睫状体透析及同种异体生物支架加固成功。术中出血少,术后不良事件少。基线时,平均BCVA为0.48 (95% CI: 0.42-0.54;20/40 Snellen),使用1.4±1.3种降眼压药物时,平均±SD眼压为20.2±6.0 mmHg。12个月时,平均服药IOP较基线降低27.1%。在基线IOP为21 mmHg (n = 45)的眼睛中,12个月时配对IOP降低39.7%,同时降低IOP的平均药物数量减少到0.8±0.9,具有统计学意义(p < 0.01)。在所有眼睛中,81.9%的患者在12个月时实现了药物IOP≤18 mmHg,且药物没有增加。3.2%的患者接受了继发性青光眼手术。结论:异体巩膜加固生物介入睫状体透析术可通过增强巩膜流出来降低眼压。
{"title":"Bio-Interventional Cyclodialysis and Allograft Scleral Reinforcement for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients: One-Year Clinical Outcomes.","authors":"Tsontcho Ianchulev, Robert N Weinreb, Ernesto A Calvo, James Lewis, Gautam Kamthan, Arsham Sheybani, Douglas J Rhee, Iqbal K Ahmed","doi":"10.2147/OPTH.S496631","DOIUrl":"10.2147/OPTH.S496631","url":null,"abstract":"<p><strong>Background: </strong>To evaluate the one-year safety and effectiveness of bio-interventional cyclodialysis and scleral reinforcement in open-angle glaucoma (OAG) patients undergoing cataract surgery.</p><p><strong>Methods: </strong>An ab-interno approach was used to create a sectoral cyclodialysis in OAG patients who were prospectively followed in a consecutive case series. Subsequent visco-cycloplasty with scleral reinforcement using homologous minimally modified allograft scaffold was completed to maintain patency of the cyclodialysis reservoir and increase uveoscleral outflow. Outcomes were mean medicated IOP and mean number of IOP-lowering medications. Safety outcomes were adverse events (AEs) and best-corrected visual acuity (BCVA) changes.</p><p><strong>Results: </strong>Successful cyclodialysis and allograft bio-scaffold reinforcement was achieved in 117 eyes. There was minimal intraoperatie bleeding and few post-operative adverse events. At baseline, mean BCVA was 0.48 (95% CI: 0.42‒0.54; 20/40 Snellen) and mean ± SD medicated IOP was 20.2 ± 6.0 mmHg on 1.4 ± 1.3 IOP-lowering medications. At 12 months, there was a 27.1% reduction from baseline mean medicated IOP. In eyes with medicated baseline IOP > 21 mmHg (n = 45), there was a 39.7% paired IOP reduction at 12 months with a concurrent reduction in the mean number of IOP lowering medications to 0.8 ± 0.9 which were statistically significant (p < 0.01). For all eyes, 81.9% achieved a medicated IOP ≤ 18 mmHg with no increase in medications at 12 months. To achieve target IOP control, secondary glaucoma surgery was performed in 3.2% of the cases.</p><p><strong>Conclusion: </strong>IOP lowering through uveoscleral outflow enhancement can be achieved by means of a bio-interventional cyclodialysis procedure with allograft scleral reinforcement.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3605-3614"},"PeriodicalIF":0.0,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11629670/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The THINK Study: Testing Hypoesthesia and the Incidence of Neurotrophic Keratopathy in Cataract Patients with Dry Eye. THINK研究:检测干眼白内障患者的感觉减退和神经营养性角膜病变的发生率。
Pub Date : 2024-12-06 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S501452
John A Hovanesian

Purpose: This study was designed to determine the frequency of neurotrophic keratopathy (NK) among patients presenting for cataract surgery consultation in a suburban US practice.

Methods: Patients presenting for cataract consultation were evaluated with corneal staining without anesthetic. Those with grade 1 or greater corneal stain and a tear breakup time (TBUT) of ≤10 underwent corneal sensitivity testing with a Cochet Bonnet esthesiometer. The study also evaluated patient SPEED score symptoms, corrected distance visual acuity (CDVA), corneal higher-order aberrations (HOAs), and conjunctival hyperemia.

Results: Among the 31 patients enrolled, mean corneal esthesiometry was 40 ± 9.5 mm (range 13 to 55). Esthesiometry of ≤40 mm, indicating neurotrophic keratopathy, was detected in 18 (58%, 95% CI 39-75%) patients. Corneal higher-order aberrations were significantly worse at 0.83 ± 0.22 µ in the group with NK vs 0.67 ± 0.16 among patients without NK (P < 0.028). A nonsignificant correlation was found between reduced corneal sensitivity and reduced symptoms. Older patients had slightly reduced sensation, but this trend was not statistically significant. No trend was seen between reduced sensation and either CDVA or corneal staining.

Conclusion: More than half of patients presenting for cataract evaluation with dry eye had stage 1 neurotrophic keratopathy. These patients had significantly worse higher-order aberrations than patients with normal sensitivity. Among patients with NK, symptoms were milder and age was higher, but neither trend was statistically significant. No trend was observed between corneal sensation and either corneal staining or CDVA.

目的:本研究旨在确定美国郊区白内障手术会诊患者中神经营养性角膜病变(NK)的频率。方法:对前来就诊的白内障患者进行无麻醉角膜染色评价。1级及以上角膜染色且TBUT≤10的患者使用Cochet Bonnet角膜感受器进行角膜敏感性测试。该研究还评估了患者的SPEED评分症状、矫正距离视力(CDVA)、角膜高阶像差(HOAs)和结膜充血。结果:在31例入组患者中,平均角膜感觉测量值为40±9.5 mm(范围13 ~ 55)。18例(58%,95% CI 39-75%)患者的感觉测量值≤40 mm,表明神经营养性角膜病变。NK组角膜高阶像差为0.83±0.22µ,NK组为0.67±0.16µ,差异有统计学意义(P < 0.028)。角膜敏感性降低与症状减轻之间无显著相关性。老年患者有轻微的感觉下降,但这种趋势在统计学上不显著。感觉减退与CDVA或角膜染色之间没有明显的联系。结论:超过一半的干眼白内障患者为1期神经营养性角膜病变。这些患者的高阶畸变明显比正常敏感性患者更严重。NK患者症状较轻,年龄较高,但两种趋势均无统计学意义。角膜感觉与角膜染色或CDVA之间均无明显变化。
{"title":"The THINK Study: Testing Hypoesthesia and the Incidence of Neurotrophic Keratopathy in Cataract Patients with Dry Eye.","authors":"John A Hovanesian","doi":"10.2147/OPTH.S501452","DOIUrl":"10.2147/OPTH.S501452","url":null,"abstract":"<p><strong>Purpose: </strong>This study was designed to determine the frequency of neurotrophic keratopathy (NK) among patients presenting for cataract surgery consultation in a suburban US practice.</p><p><strong>Methods: </strong>Patients presenting for cataract consultation were evaluated with corneal staining without anesthetic. Those with grade 1 or greater corneal stain and a tear breakup time (TBUT) of ≤10 underwent corneal sensitivity testing with a Cochet Bonnet esthesiometer. The study also evaluated patient SPEED score symptoms, corrected distance visual acuity (CDVA), corneal higher-order aberrations (HOAs), and conjunctival hyperemia.</p><p><strong>Results: </strong>Among the 31 patients enrolled, mean corneal esthesiometry was 40 ± 9.5 mm (range 13 to 55). Esthesiometry of ≤40 mm, indicating neurotrophic keratopathy, was detected in 18 (58%, 95% CI 39-75%) patients. Corneal higher-order aberrations were significantly worse at 0.83 ± 0.22 µ in the group with NK vs 0.67 ± 0.16 among patients without NK (P < 0.028). A nonsignificant correlation was found between reduced corneal sensitivity and reduced symptoms. Older patients had slightly reduced sensation, but this trend was not statistically significant. No trend was seen between reduced sensation and either CDVA or corneal staining.</p><p><strong>Conclusion: </strong>More than half of patients presenting for cataract evaluation with dry eye had stage 1 neurotrophic keratopathy. These patients had significantly worse higher-order aberrations than patients with normal sensitivity. Among patients with NK, symptoms were milder and age was higher, but neither trend was statistically significant. No trend was observed between corneal sensation and either corneal staining or CDVA.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3627-3633"},"PeriodicalIF":0.0,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11630729/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Demographic Modifiers on Readability of Myopia Education Materials Generated by Large Language Models. 大语言模型生成的近视教育材料中人口统计学修饰符对可读性的影响。
Pub Date : 2024-12-04 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S483024
Gabriela G Lee, Deniz Goodman, Ta Chen Peter Chang

Background: The rise of large language models (LLM) promises to widely impact healthcare providers and patients alike. As these tools reflect the biases of currently available data on the internet, there is a risk that increasing LLM use will proliferate these biases and affect information quality. This study aims to characterize the effects of different race, ethnicity, and gender modifiers in question prompts presented to three large language models (LLM) on the length and readability of patient education materials about myopia.

Methods: ChatGPT, Gemini, and Copilot were provided a standardized prompt incorporating demographic modifiers to inquire about myopia. The races and ethnicities evaluated were Asian, Black, Hispanic, Native American, and White. Gender was limited to male or female. The prompt was inserted five times into new chat windows. Responses were analyzed for readability by word count, Simple Measure of Gobbledygook (SMOG) index, Flesch-Kincaid Grade Level, and Flesch Reading Ease score. Significant differences were analyzed using two-way ANOVA on SPSS.

Results: A total of 150 responses were analyzed. There were no differences in SMOG index, Flesch-Kincaid Grade Level, or Flesch Reading Ease scores between responses generated with prompts containing different gender, race, or ethnicity modifiers using ChatGPT or Copilot. Gemini-generated responses differed significantly in their SMOG Index, Flesch-Kincaid Grade Level, and Flesch Reading Ease based on the race mentioned in the prompt (p<0.05).

Conclusion: Patient demographic information impacts the reading level of educational material generated by Gemini but not by ChatGPT or Copilot. As patients use LLMs to understand ophthalmologic diagnoses like myopia, clinicians and users should be aware of demographic influences on readability. Patient gender, race, and ethnicity may be overlooked variables affecting the readability of LLM-generated education materials, which can impact patient care. Future research could focus on the accuracy of generated information to identify potential risks of misinformation.

背景:大型语言模型(LLM)的兴起有望广泛影响医疗保健提供者和患者。由于这些工具反映了互联网上当前可用数据的偏差,因此法学硕士使用的增加可能会增加这些偏差并影响信息质量。本研究旨在探讨不同种族、民族和性别修饰语对三种大型语言模型(LLM)患者近视教育材料长度和可读性的影响。方法:对ChatGPT、Gemini和Copilot进行纳入人口统计学修饰词的标准化提示询问近视情况。被评估的种族和民族包括亚洲人、黑人、西班牙人、美洲原住民和白人。性别仅限于男性或女性。在新的聊天窗口中插入了五次提示符。通过字数统计、简单测量的Gobbledygook (SMOG)指数、Flesch- kincaid等级水平和Flesch阅读易用性评分来分析回复的可读性。采用SPSS的双向方差分析分析显著差异。结果:共分析了150份问卷。在使用ChatGPT或Copilot使用包含不同性别、种族或民族修饰符的提示生成的回答之间,烟雾指数、Flesch- kinaid Grade Level或Flesch Reading Ease得分没有差异。根据提示中提到的种族,双子座生成的回答在SMOG指数、Flesch- kincaid Grade Level和Flesch Reading Ease方面存在显著差异(pConclusion:患者人口统计信息影响双子座生成的教育材料的阅读水平,而ChatGPT或Copilot生成的教育材料没有影响。)当患者使用llm来理解近视等眼科诊断时,临床医生和用户应该意识到人口统计学对可读性的影响。患者的性别、种族和民族可能被忽视的变量影响法学硕士生成的教育材料的可读性,这可能会影响患者的护理。未来的研究可以关注生成信息的准确性,以识别错误信息的潜在风险。
{"title":"Impact of Demographic Modifiers on Readability of Myopia Education Materials Generated by Large Language Models.","authors":"Gabriela G Lee, Deniz Goodman, Ta Chen Peter Chang","doi":"10.2147/OPTH.S483024","DOIUrl":"10.2147/OPTH.S483024","url":null,"abstract":"<p><strong>Background: </strong>The rise of large language models (LLM) promises to widely impact healthcare providers and patients alike. As these tools reflect the biases of currently available data on the internet, there is a risk that increasing LLM use will proliferate these biases and affect information quality. This study aims to characterize the effects of different race, ethnicity, and gender modifiers in question prompts presented to three large language models (LLM) on the length and readability of patient education materials about myopia.</p><p><strong>Methods: </strong>ChatGPT, Gemini, and Copilot were provided a standardized prompt incorporating demographic modifiers to inquire about myopia. The races and ethnicities evaluated were Asian, Black, Hispanic, Native American, and White. Gender was limited to male or female. The prompt was inserted five times into new chat windows. Responses were analyzed for readability by word count, Simple Measure of Gobbledygook (SMOG) index, Flesch-Kincaid Grade Level, and Flesch Reading Ease score. Significant differences were analyzed using two-way ANOVA on SPSS.</p><p><strong>Results: </strong>A total of 150 responses were analyzed. There were no differences in SMOG index, Flesch-Kincaid Grade Level, or Flesch Reading Ease scores between responses generated with prompts containing different gender, race, or ethnicity modifiers using ChatGPT or Copilot. Gemini-generated responses differed significantly in their SMOG Index, Flesch-Kincaid Grade Level, and Flesch Reading Ease based on the race mentioned in the prompt (p<0.05).</p><p><strong>Conclusion: </strong>Patient demographic information impacts the reading level of educational material generated by Gemini but not by ChatGPT or Copilot. As patients use LLMs to understand ophthalmologic diagnoses like myopia, clinicians and users should be aware of demographic influences on readability. Patient gender, race, and ethnicity may be overlooked variables affecting the readability of LLM-generated education materials, which can impact patient care. Future research could focus on the accuracy of generated information to identify potential risks of misinformation.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3591-3604"},"PeriodicalIF":0.0,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11625417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ahmed Glaucoma Valve Implantation in Jordan: Indications and Complications. 约旦Ahmed青光眼瓣膜植入术:适应症和并发症。
Pub Date : 2024-12-04 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S496586
Asem A Alqudah, Ahmed G Obaidi, Mohammad Al Zoubi, Abdelwahab Aleshawi

Aim: The main indications for Ahmed glaucoma valve (AGV) include neovascular glaucoma, congenital glaucoma, primary open angle glaucoma and patients with failed previous trabeculectomy. This article aims to investigate the complications of AGV in Jordanian glaucoma patients and to justify the main risk factors.

Methods: Retrospectively, we report 87 eyes of 83 patients who underwent AGV implantation for different indications. The database included demographic data, past ocular and medical history, the indication for surgery, the perioperative outcome parameters at different follow-up visits, and the developed complications at each post-operative visit.

Results: More than half of the patients (54%) were males. The mean age of the patients was 47.4 years. Neovascular glaucoma was the most common indication for AGV implantation. Valve encapsulation was the most encountered complication. About one quarter of the eyes at one time underwent valve revision. Younger patients, neovascular glaucoma and congenital glaucoma were associated significantly with AGV failure and for the need for revision surgery.

Conclusion: AGV is the predominant glaucoma surgery performed in Jordan. Valve encapsulation is the most common complication for AGV implant in Jordanian patients which may be related to racial and genetic factors. Neovascular glaucoma has a high burden in Jordan and secondary causes should be controlled adequately.

目的:Ahmed青光眼瓣膜(AGV)的主要适应症包括新生血管性青光眼、先天性青光眼、原发性开角型青光眼和既往小梁切除术失败的患者。本文旨在探讨AGV在约旦青光眼患者中的并发症,并证明其主要危险因素。方法:回顾性报道83例87眼不同适应症的AGV植入术。该数据库包括人口统计资料、既往眼科病史和病史、手术指征、不同随访的围手术期结局参数以及每次术后随访时发生的并发症。结果:半数以上(54%)患者为男性。患者平均年龄47.4岁。新血管性青光眼是AGV植入术最常见的适应症。瓣膜封装是最常见的并发症。大约四分之一的眼睛在同一时间进行了瓣膜修复。年轻患者、新生血管性青光眼和先天性青光眼与AGV失败和需要翻修手术显著相关。结论:AGV是约旦主要的青光眼手术。瓣膜包封是约旦患者最常见的AGV植入并发症,可能与种族和遗传因素有关。在约旦,新生血管性青光眼的负担很高,继发原因应得到充分控制。
{"title":"Ahmed Glaucoma Valve Implantation in Jordan: Indications and Complications.","authors":"Asem A Alqudah, Ahmed G Obaidi, Mohammad Al Zoubi, Abdelwahab Aleshawi","doi":"10.2147/OPTH.S496586","DOIUrl":"10.2147/OPTH.S496586","url":null,"abstract":"<p><strong>Aim: </strong>The main indications for Ahmed glaucoma valve (AGV) include neovascular glaucoma, congenital glaucoma, primary open angle glaucoma and patients with failed previous trabeculectomy. This article aims to investigate the complications of AGV in Jordanian glaucoma patients and to justify the main risk factors.</p><p><strong>Methods: </strong>Retrospectively, we report 87 eyes of 83 patients who underwent AGV implantation for different indications. The database included demographic data, past ocular and medical history, the indication for surgery, the perioperative outcome parameters at different follow-up visits, and the developed complications at each post-operative visit.</p><p><strong>Results: </strong>More than half of the patients (54%) were males. The mean age of the patients was 47.4 years. Neovascular glaucoma was the most common indication for AGV implantation. Valve encapsulation was the most encountered complication. About one quarter of the eyes at one time underwent valve revision. Younger patients, neovascular glaucoma and congenital glaucoma were associated significantly with AGV failure and for the need for revision surgery.</p><p><strong>Conclusion: </strong>AGV is the predominant glaucoma surgery performed in Jordan. Valve encapsulation is the most common complication for AGV implant in Jordanian patients which may be related to racial and genetic factors. Neovascular glaucoma has a high burden in Jordan and secondary causes should be controlled adequately.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3581-3590"},"PeriodicalIF":0.0,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11625418/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical ophthalmology (Auckland, N.Z.)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1